Logo image of ATEX

ANTERIX INC (ATEX) Stock Fundamental Analysis

NASDAQ:ATEX - Nasdaq - US03676C1009 - Common Stock - Currency: USD

30.12  +0.32 (+1.07%)

Premarket: 30 -0.12 (-0.4%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ATEX. ATEX was compared to 31 industry peers in the Diversified Telecommunication Services industry. The financial health of ATEX is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ATEX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATEX had negative earnings in the past year.
ATEX had a negative operating cash flow in the past year.
In the past 5 years ATEX always reported negative net income.
In multiple years ATEX reported negative operating cash flow during the last 5 years.
ATEX Yearly Net Income VS EBIT VS OCF VS FCFATEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

The Return On Assets of ATEX (-9.18%) is worse than 77.42% of its industry peers.
ATEX has a worse Return On Equity (-20.72%) than 67.74% of its industry peers.
Industry RankSector Rank
ROA -9.18%
ROE -20.72%
ROIC N/A
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ATEX Yearly ROA, ROE, ROICATEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEX Yearly Profit, Operating, Gross MarginsATEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K

More info and screens

6

2. Health

2.1 Basic Checks

ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATEX has been reduced compared to 1 year ago.
ATEX has more shares outstanding than it did 5 years ago.
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ATEX Yearly Shares OutstandingATEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ATEX Yearly Total Debt VS Total AssetsATEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.30, we must say that ATEX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ATEX (-0.30) is worse than 80.65% of its industry peers.
There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACCN/A
WACC9.04%
ATEX Yearly LT Debt VS Equity VS FCFATEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 1.65 indicates that ATEX should not have too much problems paying its short term obligations.
ATEX's Current ratio of 1.65 is fine compared to the rest of the industry. ATEX outperforms 77.42% of its industry peers.
A Quick Ratio of 1.65 indicates that ATEX should not have too much problems paying its short term obligations.
ATEX has a better Quick ratio (1.65) than 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
ATEX Yearly Current Assets VS Current LiabilitesATEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ATEX have decreased strongly by -454.35% in the last year.
Looking at the last year, ATEX shows a very strong growth in Revenue. The Revenue has grown by 66.68%.
The Revenue has been decreasing by -8.40% on average over the past years.
EPS 1Y (TTM)-454.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1950%
Revenue 1Y (TTM)66.68%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%23.21%

3.2 Future

ATEX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -22.81% yearly.
The Revenue is expected to grow by 30.56% on average over the next years. This is a very strong growth
EPS Next Y-82.11%
EPS Next 2Y4%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue Next Year36.61%
Revenue Next 2Y18.53%
Revenue Next 3Y30.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ATEX Yearly Revenue VS EstimatesATEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ATEX Yearly EPS VS EstimatesATEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ATEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEX Price Earnings VS Forward Price EarningsATEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEX Per share dataATEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

A cheap valuation may be justified as ATEX's earnings are expected to decrease with -22.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4%
EPS Next 3Y-22.81%

More info and screens

0

5. Dividend

5.1 Amount

ATEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTERIX INC

NASDAQ:ATEX (4/24/2025, 8:00:00 PM)

Premarket: 30 -0.12 (-0.4%)

30.12

+0.32 (+1.07%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)06-24 2025-06-24/amc
Inst Owners86.5%
Inst Owner Change0.04%
Ins Owners1.73%
Ins Owner Change2.22%
Market Cap559.93M
Analysts82.22
Price Target89.25 (196.31%)
Short Float %4.6%
Short Ratio4.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)78.24%
Min EPS beat(2)-14.66%
Max EPS beat(2)171.14%
EPS beat(4)1
Avg EPS beat(4)13.25%
Min EPS beat(4)-83.01%
Max EPS beat(4)171.14%
EPS beat(8)5
Avg EPS beat(8)63.41%
EPS beat(12)7
Avg EPS beat(12)16.89%
EPS beat(16)9
Avg EPS beat(16)12.85%
Revenue beat(2)0
Avg Revenue beat(2)-13.83%
Min Revenue beat(2)-14.71%
Max Revenue beat(2)-12.96%
Revenue beat(4)0
Avg Revenue beat(4)-16.2%
Min Revenue beat(4)-32.26%
Max Revenue beat(4)-4.87%
Revenue beat(8)1
Avg Revenue beat(8)-18.35%
Revenue beat(12)2
Avg Revenue beat(12)-13.91%
Revenue beat(16)4
Avg Revenue beat(16)-13.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.36%
EPS NY rev (1m)0%
EPS NY rev (3m)43.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 94.87
P/FCF N/A
P/OCF N/A
P/B 3.87
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.32
BVpS7.79
TBVpS-5.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.18%
ROE -20.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2250.98%
Cap/Sales 252.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -0.3
F-Score4
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)1951.72%
Cap/Depr(5y)1293.44%
Cap/Sales(3y)1454.89%
Cap/Sales(5y)1277.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-454.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1950%
EPS Next Y-82.11%
EPS Next 2Y4%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue 1Y (TTM)66.68%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%23.21%
Revenue Next Year36.61%
Revenue Next 2Y18.53%
Revenue Next 3Y30.56%
Revenue Next 5YN/A
EBIT growth 1Y4.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-503.81%
EBIT Next 3Y-55.59%
EBIT Next 5YN/A
FCF growth 1Y63.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.38%
OCF growth 3YN/A
OCF growth 5YN/A